Both in Biotechnology
Sutro Biopharma vs Protara Therapeutics
Over the past year STRO returned −17.2% and TARA returned −52.9%; their daily moves had a correlation of 0.31.
STRO −17.2% TARA −52.9%Growth of $1, one year, split-adjusted
| Metric | STRO | TARA |
|---|---|---|
| Price | $9.11 | $2.41 |
| Market cap | $151.1M | $142.4M |
| Today | +0.11% | −2.82% |
| 1 month | −40.7% | −10.7% |
| 6 months | −76.3% | −55.8% |
| Year to date | −21.3% | −54.8% |
| 1 year | −21.5% | −53.1% |
| Revenue growth (YoY) | −84.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −391.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $164.3M | $142.5M |
| Dividend yield | — | — |
| Volatility (60d) | 73.4% | 49.0% |
| Short % of float | 13.1% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).